Neurovascular complications of antiphospholipid syndrome: a narrative review.

George Nilton Nunes Mendes, Alessandra Braga Cruz Guedes de Morais, Laura Catherine Gioia, Grégory Jacquin, Alexandre Y Poppe, Felipe Hideki Soga, João Brainer Clares de Andrade

Journal: Arquivos de neuro-psiquiatria 2024;82(12):1-7

PMID: 39658037

Abstract

BACKGROUND

 Antiphospholipid syndrome (APS) is a systemic autoimmune disorder characterized by thrombosis, pregnancy complications, and other nonthrombotic manifestations in the presence of antiphospholipid antibodies. Neurovascular complications, including ischemic stroke, cerebral venous thrombosis and cognitive impairment, pose significant challenges in management.

OBJECTIVE

 To comprehensively review relevant and updated clinical aspects of neurovascular manifestations of APS.

METHODS

 We conducted a narrative review using the PubMed, EMBASE, and Cochrane Library databases with medical terms related to APS and its neurovascular manifestations. English-language studies, published between January 1, 2015, and March 2024, were included. Key publications outside this timeframe were also considered. Studies with higher levels of evidence, such as randomized controlled trials and meta-analyses, were prioritized for inclusion.

RESULTS

 Stroke is a prevalent complication in APS, with arterial thrombosis being a predominant mechanism. Despite recent trials, direct oral anticoagulants (DOACs) have not shown superiority over vitamin K antagonists (VKAs) for secondary prevention in this population. Cerebral venous thrombosis (CVT), although rare, can also occur in APS, and while DOACs have shown promise as a treatment in a general population, caution is warranted due to potential harm. Cognitive impairment affects a considerable proportion of APS patients, with thrombotic and nonthrombotic mechanisms contributing to its pathophysiology. Future research should focus on optimal management strategies for cognitive impairment and the efficacy of anticoagulation and immunosuppression.

CONCLUSION

 Understanding the complex interplay of neurovascular manifestations in APS is essential for guiding clinical decisions and improving patient outcomes. Despite advancements, some challenges remain in establishing effective preventive and treatment measures, highlighting the need for further research in this field.

The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution 4.0 International License, permitting copying and reproduction so long as the original work is given appropriate credit (https://creativecommons.org/licenses/by/4.0/).

Address: Université de Montréal, Centre Hospitalier, Programme de Santé Neurovasculaire, Montréal Québec, Canada.; Université de Montréal, Centre Hospitalier, Centre de Recherche, Axe Neurosciences, Montréal Québec, Canada.; Universidade Federal de São Paulo, São Paulo SP, Brazil.; Université de Montréal, Centre Hospitalier, Programme de Santé Neurovasculaire, Montréal Québec, Canada.; Université de Montréal, Centre Hospitalier, Centre de Recherche, Axe Neurosciences, Montréal Québec, Canada.; Université de Montréal, Faculté de Médecine, Département de Neurosciences, Montréal Québec, Canada.; Centro Universitário São Camilo, São Paulo SP, Brazil.; Universidade Federal de São Paulo, São Paulo SP, Brazil.; Centro Universitário São Camilo, São Paulo SP, Brazil.; Hospital Israelita Albert Einstein, São Paulo SP, Brazil.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.